The top 3 holdings of LABU are Alnylam Pharmaceuticals (ALNY) (2.146%), Insmed (INSM) (1.937%) and Halozyme Therapeutics (HALO) (1.918%).

FUND	HOLDING	% OF FUND	VALUE ($)
LABU	Alnylam Pharmaceuticals (ALNY)	2.146%	$13.8M
LABU	Insmed (INSM)	1.937%	$12.4M
LABU	Halozyme Therapeutics (HALO)	1.918%	$12.3M
LABU	Incyte (INCY)	1.739%	$11.2M
LABU	Regeneron Pharmaceuticals (REGN)	1.598%	$10.3M
LABU	Neurocrine Biosciences (NBIX)	1.57%	$10.1M
LABU	United Therapeutics (UTHR)	1.558%	$10M
LABU	AbbVie (ABBV)	1.533%	$9.8M
LABU	Madrigal Pharmaceuticals (MDGL)	1.531%	$9.8M
LABU	Gilead Sciences (GILD)	1.47%	$9.4M
LABU	Biomarin Pharmaceutical (BMRN)	1.448%	$9.3M
LABU	Biogen (BIIB)	1.446%	$9.3M
LABU	BridgeBio Pharma (BBIO)	1.432%	$9.2M
LABU	Amgen (AMGN)	1.392%	$8.9M
LABU	Natera (NTRA)	1.379%	$8.9M
LABU	Exelixis (EXEL)	1.311%	$8.4M
LABU	Moderna (MRNA)	1.276%	$8.2M
LABU	Vertex Pharmaceuticals (VRTX)	1.213%	$7.8M
LABU	EXACT Sciences (EXAS)	1.184%	$7.6M
LABU	Roivant Sciences (ROIV)	1.04%	$6.7M
LABU	Cytokinetics (CYTK)	0.941%	$6M
LABU	Ionis Pharmaceuticals (IONS)	0.908%	$5.8M
LABU	Crispr Therapeutics (CRSP)	0.898%	$5.8M
LABU	Avidity Biosciences (RNA)	0.891%	$5.7M
LABU	Revolution Medicines (RVMD)	0.854%	$5.5M

Holdings are tracked for approximately 2000 ETFs.